|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen X, Zeng K, Xu M, Hu X, Liu X, Xu T,
He B, Pan Y, Sun H and Wang S: SP1-induced lncRNA-ZFAS1 contributes
to colorectal cancer progression via the miR-150-5p/VEGFA axis.
Cell death & disease. 9:1–18. 2018. View Article : Google Scholar
|
|
3
|
Ahmed S, Johnson K, Ahmed O and Iqbal N:
Advances in the management of colorectal cancer: From biology to
treatment. Int J Colorectal Dis. 29:1031–1042. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mele V, Sokol L, Kölzer VH, Pfaff D,
Muraro MG, Keller I, Stefan Z, Centeno I, Terracciano LM, Dawson H,
et al: The hyaluronan-mediated motility receptor RHAMM promotes
growth, invasiveness and dissemination of colorectal cancer.
Oncotarget. 8:70617–70629. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang KM, Park IJ, Lee JL, Kim CW, Yoon YS,
Lim SB, Yu CS and Kim JC: Benefits of repeated resections for liver
and lung metastases from colorectal cancer. Asian J Surg.
43:102–109. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gulinaer AJ, Ju AN, Gao M, Luo Y and Bo
YL: Over-expression of miR-187 inhibited cell proliferation and
metastasis of glioma via down-regulating SMAD1. Eur Rev Med
Pharmacol Sci. 23:10908–10917. 2019.PubMed/NCBI
|
|
8
|
Jiang Y, Wang X, Zhang J and Lai R:
MicroRNA-599 suppresses glioma progression by targeting RAB27B.
Oncol Lett. 16:1243–1252. 2018.PubMed/NCBI
|
|
9
|
Sheng XY, Wang CH, Wang CF and Xu HY:
Long-chain non-coding SOX21-AS1 promotes proliferation and
migration of breast cancer cells through the PI3K/AKT signaling
pathway. Cancer Manag Res. 12:11005–11014. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang G, Luo L, Zhang J, Zhai D, Huang D,
Yin J, Zhou Q, Zhang Q and Zheng G: lncRNA LINC01057 promotes
mesenchymal differentiation by activating NF-KB signaling in
glioblastoma. Cancer Lett. October 31–2020.(Online ahead of
print).
|
|
11
|
Liu Y, Yang Y, Li L, Liu Y, Geng P, Li G
and Song H: LncRNA SNHG1 enhances cell proliferation, migration,
and invasion in cervical cancer. Biochem Cell Biol. 96:38–43. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang L, Froberg JE and Lee JT: Long
noncoding RNAs: FResh perspectives into the RNA world. Trends
Biochem Sci. 39:35–43. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang H, Bai M, Zeng A, Si L, Yu N and
Wang X: LncRNA HOXD-AS1 promotes melanoma cell proliferation and
invasion by suppressing RUNX3 expression. Am J Cancer Res.
7:2526–2535. 2017.PubMed/NCBI
|
|
15
|
Lian Y, Cai Z, Gong H, Xue S, Wu D and
Wang K: HOTTIP: A critical oncogenic long non-coding RNA in human
cancers. Mol Biosyst. 12:3247–3253. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lv M, Zhong Z, Huang M, Tian Q, Jiang R
and Chen J: lncRNA H19 regulates epithelial-mesenchymal transition
and metastasis of bladder cancer by miR-29b-3p as competing
endogenous RNA. Biochim Biophys Acta Mol Cell Res. 1864:1887–1899.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li C, Ye J, Zhang Z, Gong Z, Lin Z and
Ding M: Long non-coding RNA RBM5-AS1 promotes the aggressive
behaviors of oral squamous cell carcinoma by regulation of
miR-1285-3p/YAP1 axis. Biomed Pharmacother. 123:1097232019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang Z, Zhang Y, Chen X, Wu P and Chen D:
Long noncoding RNA RBMS3-AS3 acts as a microRNA-4534 sponge to
inhibit the progression of prostate cancer by upregulating VASH1.
Gene Ther. 27:143–156. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang YT and Yang GY: LncRNA SNHG17 acts
as a ceRNA of miR-324-3p to contribute the progression of
osteosarcoma. J Biol Regul Homeost Agents. 34:1529–1533.
2020.PubMed/NCBI
|
|
20
|
Yang C, Zheng J, Xue Y, Yu H, Liu X, Ma J,
Liu L, Wang P, Li Z, Cai H and Liu Y: The effect of
MCM3AP-AS1/miR-211/KLF5/AGGF1 axis regulating glioblastoma
angiogenesis. Front Mol Neurosci. 10:4372018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Yu M and Yang C: YY1-mediated
overexpression of long noncoding RNA MCM3AP-AS1 accelerates
angiogenesis and progression in lung cancer by targeting
miR-340-5p/KPNA4 axis. J Cell Biochem. 121:2258–2267. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang M, Sun S, Guo Y, Qin J and Liu G:
Long non-coding RNA MCM3AP-AS1 promotes growth and migration
through modulating FOXK1 by sponging miR-138-5p in pancreatic
cancer. Mol Med. 25:552019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Paraskevopoulou MD and Hatzigeorgiou AG:
Analyzing MiRNA-LncRNA interactions. Methods Mol Biol.
1402:271–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Z, Li Z, Xu B, Yao H, Qi S and Tai J:
Long noncoding RNA PRR34-AS1 aggravates the progression of
hepatocellular carcinoma by adsorbing microRNA-498 and thereby
upregulating FOXO3. Cancer Manag Res. 12:10749–10762. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang S, Wang T, Liu D and Kong H: LncRNA
MALAT1 aggravates the progression of non-small cell lung cancer by
stimulating the expression of COMMD8 via targeting miR-613. Cancer
Manag Res. 12:10735–10747. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou Y, Shi H, Du Y, Zhao G, Wang X, Li Q,
Liu J, Ye L, Shen Z, Guo Y and Huang Y: lncRNA DLEU2 modulates cell
proliferation and invasion of non-small cell lung cancer by
regulating miR-30c-5p/SOX9 axis. Aging (Albany NY). 11:7386–7401.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zou P, Zhu M, Lian C, Wang J, Chen Z,
Zhang X, Yang Y, Chen X, Cui X, Liu J, et al: miR-192-5p suppresses
the progression of lung cancer bone metastasis by targeting TRIM44.
Sci Rep. 9:196192019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen L, Wang X, Ji C, Hu J and Fang L:
MiR-506-3p suppresses papillary thyroid cancer cells tumorigenesis
by targeting YAP1. Pathol Res Pract. 216:1532312020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang ZZ, Luo YR, Du J, Yu Y, Yang XZ, Cui
YJ and Jin XF: MiR-296-5p inhibits cell invasion and migration of
esophageal squamous cell carcinoma by downregulating STAT3
signaling. Eur Rev Med Pharmacol Sci. 23:5206–5214. 2019.PubMed/NCBI
|
|
31
|
Li B, Mao R, Liu C, Zhang W, Tang Y and
Guo Z: LncRNA FAL1 promotes cell proliferation and migration by
acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells.
Life Sci. 197:122–129. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiao C, Song Z, Chen J, Zhong J, Cai W,
Tian S, Chen S, Yi Y and Xiao Y: lncRNA-UCA1 enhances cell
proliferation through functioning as a ceRNA of Sox4 in esophageal
cancer. Oncol Rep. 36:2960–2966. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liang M, Jia J, Chen L, Wei B, Guan Q,
Ding Z, Yu J, Pang R and He G: LncRNA MCM3AP-AS1 promotes
proliferation and invasion through regulating miR-211-5p/SPARC axis
in papillary thyroid cancer. Endocrine. 65:318–326. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu
Q, Tong X, Yang W, Xu Q, Huang D and Tu K: A novel lncRNA
MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by
targeting miR-194-5p/FOXA1 axis. Mol Cancer. 18:282019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gong Y, Wu W, Zou X, Liu F, Wei T and Zhu
J: MiR-26a inhibits thyroid cancer cell proliferation by targeting
ARPP19. Am J Cancer Res. 8:1030–1039. 2018.PubMed/NCBI
|
|
36
|
Wang J, Wang B, Ren H and Chen W: miR-9-5p
inhibits pancreatic cancer cell proliferation, invasion and
glutamine metabolism by targeting GOT1. Biochem Biophys Res Commun.
509:241–248. 2019. View Article : Google Scholar : PubMed/NCBI
|
